Barclays’s Fate Therapeutics FATE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $507K | Buy |
453,072
+85,787
| +23% | +$96K | ﹤0.01% | 3037 |
|
|
2025
Q1 | $290K | Sell |
367,285
-49,446
| -12% | -$39K | ﹤0.01% | 3146 |
|
|
2024
Q4 | $687K | Sell |
416,731
-7,546
| -2% | -$12.4K | ﹤0.01% | 2868 |
|
|
2024
Q3 | $1.49M | Buy |
424,277
+301,389
| +245% | +$1.05M | ﹤0.01% | 2390 |
|
|
2024
Q2 | $403K | Sell |
122,888
-201,355
| -62% | -$660K | ﹤0.01% | 2660 |
|
|
2024
Q1 | $2.38M | Sell |
324,243
-35,132
| -10% | -$258K | ﹤0.01% | 1826 |
|
|
2023
Q4 | $1.34M | Buy |
359,375
+240,624
| +203% | +$900K | ﹤0.01% | 2414 |
|
|
2023
Q3 | $252K | Sell |
118,751
-360,348
| -75% | -$765K | ﹤0.01% | 2927 |
|
|
2023
Q2 | $2.28M | Sell |
479,099
-21,723
| -4% | -$103K | ﹤0.01% | 1665 |
|
|
2023
Q1 | $2.86M | Buy |
500,822
+236,947
| +90% | +$1.35M | ﹤0.01% | 1417 |
|
|
2022
Q4 | $2.66M | Buy |
263,875
+84,960
| +47% | +$857K | ﹤0.01% | 1465 |
|
|
2022
Q3 | $4.01M | Buy |
178,915
+158,098
| +759% | +$3.54M | ﹤0.01% | 1225 |
|
|
2022
Q2 | $516K | Sell |
20,817
-581
| -3% | -$14.4K | ﹤0.01% | 2530 |
|
|
2022
Q1 | $830K | Sell |
21,398
-84,820
| -80% | -$3.29M | ﹤0.01% | 2451 |
|
|
2021
Q4 | $6.22M | Buy |
106,218
+51,470
| +94% | +$3.01M | ﹤0.01% | 1113 |
|
|
2021
Q3 | $3.24M | Buy |
54,748
+12,204
| +29% | +$723K | ﹤0.01% | 1525 |
|
|
2021
Q2 | $3.69M | Sell |
42,544
-67,235
| -61% | -$5.84M | ﹤0.01% | 1362 |
|
|
2021
Q1 | $9.05M | Sell |
109,779
-20,070
| -15% | -$1.65M | ﹤0.01% | 872 |
|
|
2020
Q4 | $11.8M | Sell |
129,849
-29,142
| -18% | -$2.65M | 0.01% | 737 |
|
|
2020
Q3 | $6.36M | Buy |
158,991
+22,337
| +16% | +$893K | ﹤0.01% | 870 |
|
|
2020
Q2 | $4.69M | Buy |
136,654
+27,082
| +25% | +$929K | ﹤0.01% | 968 |
|
|
2020
Q1 | $2.43M | Buy |
109,572
+48,919
| +81% | +$1.09M | ﹤0.01% | 1239 |
|
|
2019
Q4 | $1.19M | Buy |
60,653
+5,468
| +10% | +$107K | ﹤0.01% | 2206 |
|
|
2019
Q3 | $858K | Sell |
55,185
-21,327
| -28% | -$332K | ﹤0.01% | 2343 |
|
|
2019
Q2 | $1.55M | Buy |
76,512
+43,706
| +133% | +$888K | ﹤0.01% | 2003 |
|
|
2019
Q1 | $576K | Buy |
32,806
+347
| +1% | +$6.09K | ﹤0.01% | 2524 |
|
|
2018
Q4 | $416K | Sell |
32,459
-1,068
| -3% | -$13.7K | ﹤0.01% | 2356 |
|
|
2018
Q3 | $547K | Buy |
33,527
+26,085
| +351% | +$426K | ﹤0.01% | 2587 |
|
|
2018
Q2 | $85K | Sell |
7,442
-11,363
| -60% | -$130K | ﹤0.01% | 3124 |
|
|
2018
Q1 | $184K | Buy |
18,805
+12,577
| +202% | +$123K | ﹤0.01% | 2881 |
|
|
2017
Q4 | $38K | Buy |
6,228
+3,545
| +132% | +$21.6K | ﹤0.01% | 3448 |
|
|
2017
Q3 | $11K | Sell |
2,683
-8,985
| -77% | -$36.8K | ﹤0.01% | 3404 |
|
|
2017
Q2 | $38K | Sell |
11,668
-13,475
| -54% | -$43.9K | ﹤0.01% | 3096 |
|
|
2017
Q1 | $115K | Buy |
+25,143
| New | +$115K | ﹤0.01% | 2773 |
|